Top

International Orthopaedics

Published in:

Open Access 01-05-2015 | Original Paper

Thirty-day readmission rate and discharge status following total hip arthroplasty using the supercapsular percutaneously-assisted total hip surgical technique

Authors: Wade Gofton, James Chow, K. Dean Olsen, David A. Fitch

Published in: International Orthopaedics | Issue 5/2015

Abstract

Purpose

Recent studies have reported nearly 40 % of costs associated with a 30-day episode-of-care for total joint replacements are due to post-discharge activities and 81 % of those are specifically due to unplanned readmissions and discharging patients to post-acute care facilities. The purpose of this study was to determine these two key variables for total hip arthroplasty (THA) patients implanted using a tissue-sparing surgical technique and to see how these values compare to those previously reported in the United States.

Methods

The healthcare databases at three institutions were searched for primary THA patients implanted using the supercapsular percutaneously-assisted total hip (SuperPath) surgical technique between January 2013 and July 2014. Data elements included 30-day all-cause readmission rate, discharge status, transfusion rate, complications, and length of stay (LOS).

Results

Data were available for 479 THAs. The 30-day all-cause readmission rate, transfusion rate, and average LOS was 2.3, 3.3 %, and 1.6 days, respectively. Over 91 % of patients were discharged routinely home, 4.1 % to skilled nursing facilities, 3.8 % to home health care, and 0.6 % to inpatient rehabilitation facilities. Complications included dislocation (0.8 %), periprosthetic fracture (0.8 %), and deep vein thrombosis (0.2 %). There were no infections reported.

Conclusions

Patients implanted using this tissue-sparing technique experienced reduced 30-day all-cause readmission rates (2.3 % vs. 4.2 %) and more were routinely discharged home (91.5 % vs. 27.3 %) than have been previously reported for patients in the United States. Use of this tissue-sparing technique has the potential to significantly reduce post-discharge costs.

Bozic KJ, Ward L, Vail TP, Maze M (2014) Bundled payments in total joint arthroplasty: targeting opportunities for quality improvement and cost reduction. Clin Orthop Relat Res 472(1):188–193. doi:10.1007/s11999-013-3034-3 CrossRefPubMedCentralPubMed

Chow J, Penenberg B, Murphy S (2011) Modified micro-superior percutaneously-assisted total hip: early experiences & case reports. Curr Rev Musculoskelet Med 4(3):146–150. doi:10.1007/s12178-011-9090-y CrossRefPubMedCentralPubMed

Pugely AJ, Callaghan JJ, Martin CT, Cram P, Gao Y (2013) Incidence of and risk factors for 30-day readmission following elective primary total joint arthroplasty: analysis from the ACS-NSQIP. J Arthroplast 28(9):1499–1504. doi:10.1016/j.arth.2013.06.032 CrossRef

Mednick RE, Alvi HM, Krishnan V, Lovecchio F, Manning DW (2014) Factors affecting readmission rates following primary total Hip arthroplasty. J Bone Joint Surg Am Vol 96(14):1201–1209. doi:10.2106/JBJS.M.00556 CrossRef

Frisch NB, Wessell NM, Charters MA, Yu S, Jeffries JJ, Silverton CD (2014) Predictors and complications of blood transfusion in total hip and knee arthroplasty. J Arthroplast. doi:10.1016/j.arth.2014.03.048

Itokawa T, Nakashima Y, Yamamoto T, Motomura G, Ohishi M, Hamai S, Akiyama M, Hirata M, Hara D, Iwamoto Y (2013) Late dislocation is associated with recurrence after total hip arthroplasty. Int Orthop 37(8):1457–1463. doi:10.1007/s00264-013-1921-6 CrossRefPubMedCentralPubMed

Swanson TV (2005) Early results of 1000 consecutive, posterior, single-incision minimally-invasive surgery total hip arthroplasties. J Arthroplast 20(Suppl 3):26–32. doi:10.1016/j.arth.2005.05.017 CrossRef

Chevillotte C, Pibarot V, Carret J, Bejui-Hugues J, Guyen O (2011) Nine years follow-up of 100 ceramic-on-ceramic total hip arthroplasty. Int Orthop 35(11):1599–1604. doi:10.1007/s00264-010-1185-3 CrossRefPubMedCentralPubMed

Bosco JA 3rd, Karkenny AJ, Hutzler LH, Slover JD, Iorio R (2014) Cost burden of 30-day readmissions following medicare total hip and knee arthroplasty. J Arthroplast 29(5):903–905. doi:10.1016/j.arth.2013.11.006 CrossRef

10.

AHRQ HCUPnet (2012) Agency for Healthcare Research and Quality H-CUPnet Database, ICD-9-CM Code 81.51 for United States in 2011. http://hcupnet.ahrq.gov/HCUPnet.jsp. Accessed 4 Sept 2014

11.

Ramos NL, Wang EL, Karia RJ, Hutzler LH, Lajam CM, Bosco JA 3rd (2014) Correlation between physician specific discharge costs, LOS, and 30-day readmission rates: an analysis of 1,831 cases. J Arthroplast 29(9):1717–1722. doi:10.1016/j.arth.2014.04.005 CrossRef

12.

Yoshihara H, Yoneoka D (2014) National trends in the utilization of blood transfusions in total hip and knee arthroplasty. J Arthroplast 29(10):1932–1937. doi:10.1016/j.arth.2014.04.029 CrossRef

13.

Tuttle JR, Ritterman SA, Cassidy DB, Anazonwu WA, Froehlich JA, Rubin LE (2014) Cost benefit analysis of topical tranexamic acid in primary total hip and knee arthroplasty. J Arthroplast 29(8):1512–1515. doi:10.1016/j.arth.2014.01.031 CrossRef

14.

Bal BS, Haltorn D, Aleto T, Barrett M (2005) Early complications of primary total hip replacement performed with a two-incision minimally invasive technique. J Bone Joint Surg Am 87(11):2432–2438. doi:10.2106/JBJS.D.02847 CrossRefPubMed

15.

Yi C, Agudelo JF, Dayton MR, Morgan SJ (2013) Early complications of anterior supine intermuscular total hip arthroplasty. Orthop 36(3):e276–e281. doi:10.3928/01477447-20130222-14 CrossRef

Title: Thirty-day readmission rate and discharge status following total hip arthroplasty using the supercapsular percutaneously-assisted total hip surgical technique
Authors: Wade Gofton
James Chow
K. Dean Olsen
David A. Fitch
Publication date: 01-05-2015
Publisher: Springer Berlin Heidelberg
Published in: International Orthopaedics / Issue 5/2015
Print ISSN: 0341-2695
Electronic ISSN: 1432-5195
DOI: https://doi.org/10.1007/s00264-014-2587-4

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Thirty-day readmission rate and discharge status following total hip arthroplasty using the supercapsular percutaneously-assisted total hip surgical technique

Abstract

Purpose

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 5/2015

Philip H. Stahel, Cyril Mauffrey (eds): Patient Safety in Surgery

Identification of the same species in at least two intra-operative samples for prosthetic joint infection diagnostics yields the best results with broad-range polymerase chain reaction

Acute and chronic menisco-capsular separation in the young athlete: diagnosis, treatment and results in thirty seven consecutive patients

Mechanical complications with one hundred and thirty eight (antibiotic-laden) cement spacers in the treatment of periprosthetic infection after total hip arthroplasty

Coating with a novel gentamicinpalmitate formulation prevents implant-associated osteomyelitis induced by methicillin-susceptible Staphylococcus aureus in a rat model

Regenerative treatment in osteochondral lesions of the talus: autologous chondrocyte implantation versus one-step bone marrow derived cells transplantation